{"version":"1.0","type":"link","title":"Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.","author_name":"Nakazawa N 외","author_url":"https://prs-insight.online/author/Nakazawa%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/129053","thumbnail_width":1200,"thumbnail_height":630}